LB Pharmaceuticals Inc.   Report issue

For profit Phase 1
Founded: New York NY United States (2015)

Organization Overview

First Clinical Trial
2019
NCT04187560
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

LB Pharmaceuticals Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

amisulpride (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Schizophrenia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1